Sumitomo Dainippon, Roivant to create £2.4bn biopharma alliance

This article was originally published here

Under the deal, Sumitomo Dainippon Pharma will have the option to acquire up to six more Vants of Roivant. Additionally, the Japanese firm will take an equity stake

The post Sumitomo Dainippon, Roivant to create £2.4bn biopharma alliance appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply